Nina Shah, MD
Advertisement
Articles by Nina Shah, MD
Advertisement
Latest Updated Articles
Dr. Shah on BCMA-Directed CAR T-Cell Therapy Research in R/R Multiple MyelomaPublished: August 14th 2020 | Updated:
Dr. Shah on Unmet Needs With CAR T-Cell Therapy in Multiple MyelomaPublished: September 15th 2021 | Updated:
Clinical Case 1: 69-Year-Old Man With Multiple Myeloma (MM)Published: December 22nd 2021 | Updated:
Dr. Shah on Updated Efficacy of JNJ-4528 in Relapsed/Refractory MyelomaPublished: August 12th 2020 | Updated:
KarMMa Study in Relapsed/Refractory Multiple MyelomaPublished: March 4th 2022 | Updated:
Exciting Results Ignite in Multiple Myeloma and CLL at ASH 2021: Perspectives From Drs Nina Shah and Jacqueline BarrientosPublished: December 12th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5